youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
1ROG:BIT
Roche Holding AG Genussscheine
€377.90
arrow_upward
+1.56%(+5.80) 1D
Sep 29, 10:07:05 AM GMT+2 · EUR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Anadolu Ajansı
·
8 hours ago
Roche forum highlights health care investment as driver of economic growth
IndexBox
·
18 hours ago
Roche Halts German Investment Decisions as Berlin Hosts Investment Summit - News and Statistics
Euronews.com
·
18 hours ago
Why pharma giant Roche is putting German investments on hold
BigGo Finance
·
19 hours ago
Roche Freezes All German Investment in Pushback Against Drug Rebate Hike to 15.5%
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia